Cory Dunn is a Principal Scientist in Gene Editing at Ensoma, where responsibilities include advancing gene editing capabilities for various disease indications since March 2025. Prior to this, Cory served as a Principal Scientist at GRO Biosciences, successfully implementing directed evolution of protein synthesis machinery from November 2021 to January 2025, and developed innovative selection assays. Cory's prior experience includes serving as Principal Investigator at the University of Helsinki, leading research on metabolic organelles and their roles in disease from July 2017 to October 2021, and establishing the Department of Molecular Biology and Genetics at Koç University from September 2009 to June 2017. Academic achievements also include a Postdoctoral Associate role at Columbia University, focusing on signaling pathways linked to tumor formation. Cory holds a Ph.D. in Cell Biology from The Johns Hopkins University School of Medicine and a B.S. in Biology from The University of Toledo.
This person is not in any teams
This person is not in any offices